Over 1.8 million nonprofits and charities for donors, volunteers and funders

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

170 Stories from Volunteers, Donors & Supporters

Andrew Z.

Donor

Rating: 5

MAPS is doing great good for mankind, by far the most worthy of support! Not only are they fighting to make the "drug war" no more, they want to use substances for the benefit of us all. Modern society has a lot of problems that used to be handled more easily when you could pick your own medicines. Prohibition must die, people need to live!

Chandra B.

Donor

Rating: 5

I love MAPS. There are so many wonderful reviews on this site already so I'll just say that I hope you guys win this much deserved award.

Donor

Rating: 5

For years, I have been a supporter of MAPS as they have struggled to spread the truth about the benefits of psychedelic substances can offer in psychological and/or physical healing. For many years, the United States government continuously threw up roadblock after roadblock when studies on psychoactive compounds were proposed; and despite that opposition, MAPS continued and in fact redoubled its efforts. I remember the day I received my MAPS publication, discussing the studies which had begun overseas to use MDMA in the treatment of Post Traumatic Stress Disorder in soldiers. I remember reading about the individuals who became trained in this new "entheogenic therapy", and feeling so proud that, in large part thanks to years of tireless labor from MAPS, these studies would soon be taking place here in the US as well. I began seeing, even in the most conservative publications, an increasing number of articles which, if not exactly embracing the idea, did acknowledge that for many people, these treatments were highly successful. I began seeing more and more studies relating to the use of psilocybin for cluster headaches, and now trials have begun using the once entirely-banned LSD: believed to have no medicinal value at all, it has not been well-studied since the mid-century. Scientists are also looking into was to use psilcybin to reduce end of life anxiety in cancer patients. In the future, we can only expect many more great insights to come out of these types of studies, and it is MAPS, in large part, who can be thanked for the many, many years of hard work that has allowed us to reach this point.

Donor

Rating: 5

I have struggled for 30 years with a debilitating mental illness. Though I have worked with many talented therapists over the years, I have been hospitalized and the best I can say is that traditional medicine has been helpful but has in no way cured my PTSD + depression. Through MAPS's help I am vastly improved, and can see my way to complete healing over the next few months. A year ago, I had not even heard of MAPS. This sounds miraculous, but it happened to me. I hope I can someday make a big donation to this extraordinary organization. I don't quite owe them my life, but my life is immeasurably better because of MAPS. This is what Steve Jobs would term an "insanely great" group of people.

Janis P.

Donor

Rating: 5

MAPS is one of the most extraordinary nonforprofit organizations I know. Their dedicated leaders, enormous volunteer base, diversity of supporters, unique expertise in the field and hard work puts them on the forefront among most effective nonforprofits today.  MAPS has been able to bring together scientists and thinkers, health practitioners and faith leaders, cutting edge research institutions and diverse ethno - cultural wisdom practitioners, visionaries and community leaders from across the globe to create more positive, more humane and more hopeful world. MAPS transformative work is providing many people with hope towards healing, recovery and wholeness when it is most needed in their lives. I am very honored to know them.

6

Donor

Rating: 5

I firmly believe in them and appreciate what they do. Thank you MAPS. You have made a difference for the better.

7

Donor

Rating: 5

MAPS is an excellent organization with great integrity and best of intentions. They work they are doing is invaluable and the brave people who stand up and fight for what they know is right in the name of helping others deserves all it can get. As they have steadily progressed with their projects and the success of their clinical studies it is only a matter of time before many people wake up and realize the importance of this work and how it has been all along, thanks to the incredibly supportive community who literally fund it all independently.

5

Donor

Rating: 5

At the forefront of human potential, I believe MAPS vision to be inspiring and valuable. Although psychedelics, entheogens and hallucinogens have played a sacred and central and role in most societies throughout history, today they are misunderstood and oppressed both culturally and politically. MAPS is leading the way in their renaissance with solid scientific research and public policy reform. Like microscopes and telescopes for a conscious psyche and humane spirit, the first time I experienced psychedelics I caught a glimpse of the potential and possible implications they hold. Used in medicine, psychiatry and spiritual practices, psychedelics can heal individuals and positively transform society and culture. The impact MAPS could contribute to human development spans wide and deep.

4

Donor

Rating: 5

MAPS has worked to keep the candle of psychedelic research going through some very dark years. It is difficult to appreciate how long they have tried to disseminate balanced and helpful information in the face of a "no tolerance" attitude and a "war on drugs" which put all substances into the same category. Now that some psychedelic research is actually taking place again after decades, MAPS is leading the way with careful studies.

4

Donor

Rating: 5

Rick Doblin, president and founder came to our university (University of West Georgia) and ave a wonderful talk. He also presented at the ClusterBuster conference because MAPS has funded research on this medical condition.